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n the United States, more than 2000 children are diagnosed with a malignant central nervous system (CNS) tumor-defined as any lesion of WHO Grade II, III, or IV-each year. 35 The vast majority of these tumors (90%) are localized within the brain parenchyma. 35 Current pediatric neurosurgery guidelines recommend that treatment of these CNS tumors should take place at specialized centers, including pediatric hospitals, with higher volumes of pediatric tumor cases, specific training, and well-established treatment protocols. 22 Nevertheless, available data in support of this recommendation are limited.
In other fields, specialty hospitals treating a single patient population have been shown to provide improved quality of care by concentrating resources and expertise. 7, 12, 13, 29 Patients undergoing complex cancer, cardiovascular, and neurosurgical procedures at these facilities have been shown to have decreased rates of morbidity and mortality. 5, 11, 21, 25 This effect is likely due to a variety of factors, including the concentration of specialized resources with high fixed/startup costs, the development of expertise through increased procedural volume, and the training and retention of specialists.
The National Association of Children's Hospitals and Related Institutions (NACHRI) recognizes over 220 specialized pediatric hospitals. To date, no large-scale national studies have examined the effects of pediatric hospital designation on the outcomes of neurosurgical procedures for malignant pediatric brain tumors. For the purpose of assessing this relationship, a national database may be uniquely useful. The largest source of nationwide patientlevel pediatric data is the Healthcare Cost and Utilization Project Kids' Inpatient Database (KID). The KID is published every 3 years using a subset of the Nationwide Inpatient Sample. KID data are compiled from pediatric patient discharges throughout the United States. The current KID dataset contains data from several million discharges annually and includes patient demographics, tumor location, admission type, and hospital factors. Using appropriate weighting, the KID data can be used to estimate 7 million discharges per year. Accordingly, the KID provides an important window into the delivery of pediatric health care in the United States. Other databases that can be used for the analysis of pediatric data include the Nationwide Inpatient Sample, individual state inpatient databases, private insurance data sets such as MarketScan and even pediatric-focused data sets. Each type of database has its own attendant strengths and weaknesses. For example, the Pediatric Health Information System (PHIS) is a quarterly database that includes data from 45 children's hospitals that are part of the Children's Hospital Association. Because we sought to compare outcomes across a broad range of payers and institutions throughout the United States, we felt that the KID would be best suited to answer our research question.
We sought to explore the relationship between hospital designation (children's hospital, pediatric ward in a general hospital, or general hospital without pediatric ward) and patient outcomes (discharge type, mortality). We hypothesized that pediatric patients with malignant brain tumors undergoing neurosurgical procedures at specialty pediatric hospitals are more likely to have routine discharges and less likely to have died during their hospitalization than those undergoing similar procedures at nonspecialized centers.
Methods

Data Sample
This study used discharge information abstracted from the KID from 2000, 2003, 2006, and 2009 . The KID is assembled every 3 years by the Agency for Healthcare Quality and Research's Healthcare Cost and Utilization Project (2000, 2003, 2006, 2009) . 2 The KID is a stratified random sample of 10% of uncomplicated in-hospital births and 80% of pediatric discharges from each nonfederal, nonrehabilitation hospital in participating states. From 2000 through 2009, the KID data sets included between 2,516,833 and 3,407,146 discharges, with weights allowing the estimation of 7,291,032-7,558,812 discharges. The 2009 KID included 44 participating states.
2 The KID's large sample size allows for analysis of uncommon conditions, such as pediatric malignant brain tumors. Additionally, the sampling method of KID includes discharge weights that allow for national estimates to be calculated. Weights are calculated by stratification of hospitals by region, urban location, teaching status, size (based on number of beds), ownership, and hospital type. Discharge weights for patients other than healthy newborns (i.e., all of the patients in this study) are calculated by dividing the total number of children in the American Hospital Association Survey by the number of adjusted discharges in the sampling frame multiplied by the frame sampling rate, and then multiplying by 4 divided by the number of quarters for which each hospital participated in the KID in the study year. The purpose of the KID is to permit nationallevel analysis of patterns of hospital use, outcomes, and charges.
Study Cohort
Patients were selected based on International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes for the diagnosis of malignant brain tumor (191.1-191.9) and an excision of a brain tumor (01.59). Documented tumor location was categorized (frontal, temporal, parietal, occipital, intraventricular, cerebellum, brainstem). Patient factors, such as race (white, black, Hispanic, Asian Pacific Islander, Native American, other), payer information (Medicare, Medicaid, private insurance, self-pay, no charge, other), and sex (male, female) were coded as categorical variables in KID. Age was converted from continuous into a categorical variable (age categories: < 1 year, 1-4 years, 5-9 years, 10-17 years, 18-20 years). KID also includes hospital factors, such as hospital size (small, medium, large, representing < 200 beds, 200-400 beds, and > 400 beds, respectively), hospital region (Northeast, Midwest, South, West), hospital teaching status (teaching, nonteaching), and hospital location (urban, rural). Hospital type based on the National Association of Pediatric Hospitals and Related Institutions (NACHRI) was recoded as "not identified as a pediatric hospital by NACHRI," "identified as a pediatric hospital by NACHRI," or "identified as a pediatric unit in a general hospital by NACHRI." Hospitals were further characterized by procedural volume, with high-volume centers being above the 90th percentile and low-volume centers representing those at or below the 90th percentile. Finally, we controlled for admission variables such as admission source (emergency room, outside hospital transfer, routine) and admission type (emergent, urgent, or elective as defined by KID database coding standards) in our analysis.
Statistical Analysis
This study used 2 primary outcomes to measure discharge quality: routine discharge and inpatient death. These were recoded as dichotomous variables for analysis (routine discharge vs nonroutine discharge, inpatient death vs alive at discharge). Routine discharge is defined as discharge to home. Two multivariate logistic regression models using survey-adjusted generalized estimating equations were fit to model these outcomes with 1 primary predictor, hospital type, and adjusting for patient demographics (including insurance status), tumor location (based on malig-nant tumor ICD-9-CM code), admission type, and hospital factors. Our primary exposure of interest was the type of pediatric hospital (pediatric hospital, pediatric unit in a general hospital, hospital without specialized pediatric unit).
Statistical significance was predetermined as p < 0.05. All descriptive univariate and multivariate analyses were conducted in SAS 9.3 (SAS Institute).
Results
Study Cohort Demographics
Over the 4 years for which KID's data are available (2000, 2003, 2006, and 2009 ) 9360 children underwent craniotomy for a malignant CNS tumor. The majority of patients were white (56.6%), and there was a slight female predominance (54.5%). As expected in this age group, the most common location for tumors was the cerebellum (23.1%), followed by the ventricles (11.9%) and the frontal lobes (10.6%) ( Table 1) .
Most patients were discharged from specialized pediatric units (41.7%) or pediatric hospitals (37.6%). Almost all patients were discharged from urban (94.5%), teaching hospitals (91.1%). With respect to admission source, most admissions were routine (52.1%), including admissions at birth, admissions from clinic, and physician referrals. The most common type of admission was elective (38.1%). Among 9350 children for whom discharge information was available, 7824 children (83.6%) had routine discharges and 1526 (16.4%) had nonroutine discharges. There were 124 in-hospital deaths (1.3%).
Outcomes: Routine Discharge
The results of our multivariate logistic regression model, including patient demographic, payer, hospital, and admission predictors of routine discharge, are presented in Table 2 . Several patient factors were independently associated with risk of routine discharge. Compared with patients 18-20 years of age, patients under 1 year of age were less likely to be routinely discharged (OR 0.6, p = 0.03) while patients 10-17 years of age were more likely to be routinely discharged (OR 1.5, p = 0.02). Compared with tumors in the frontal lobe, tumors located in the cerebellum (OR 0.5, p < 0.001), brainstem (OR 0.2, p < 0.001), ventricles (OR 0.3, p < 0.001), and other locations (cerebrum other than lobes OR 0.4, p < 0.001, other location and location unspecified OR 0.4, p < 0.001) were much less likely to have routine discharge.
Even after controlling for patient and admission factors, we found that several hospital factors were also significantly associated with rate of routine discharge. When compared with dedicated pediatric hospitals, general hospitals with pediatric units (OR 0.4, p < 0.01), and general (nonpediatric) hospitals (OR 0.5, p < 0.01) were associated 
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with a significantly decreased likelihood of routine discharge. Even after controlling for other hospital, patient and admission factors, children treated at hospitals with more than 400 beds (OR 1.8, p = 0.02) and teaching institutions (OR 1.7, p = 0.02) were also more likely to have a routine discharge. We analyzed hospital volume using multiple methods, including as a continuous variable, by quartiles, and as a dichotomous variable (more than vs less than 15 cases per year and also above vs below the 90th percentile for volume). Higher-volume hospitals were not more likely to have routine discharges than lower-volume hospitals.
After controlling for patient and hospital factors, we found that admission factors were also associated with decreased rate of routine discharge. Compared with elective admissions, emergent admissions were less likely to be associated with routine discharges (OR 0.7, p < 0.01). Similarly, compared with routine admissions, patients admitted from the emergency room (OR 0.7, p < 0.01) and transferred from outside hospitals (OR 0.5, p < 0.01) were less likely to have routine discharges.
Outcomes: Mortality
The results of our multivariate logistic regression model, including patient, hospital, and admission predictors of inpatient mortality, are presented in Table 3 .
Hospital factors, including size, teaching status, location, and volume, were not associated with mortality. After controlling for other patient, hospital, and admission factors, we found that pediatric specialty hospitals and pediatric units were not less likely to have inpatient deaths than nonpediatric hospitals. We analyzed hospital volume using multiple methods, including as a continuous vari- able, by quartiles, and as a dichotomous variable (more than vs less than 15 cases per year and also above vs below the 90th percentile for volume). Higher-volume hospitals were not less likely to have inpatient deaths than lowervolume hospitals Several admissions factors were associated with increased likelihood of inpatient mortality. Patients transferred from another hospital were more likely to die in the hospital than patients admitted in a routine fashion (OR 5.0, p < 0.001). Patients admitted emergently were more likely to die in the hospital than patients admitted on an elective basis (OR 2.8, p = 0.04).
Discussion
We present the results of the first analysis of the relationship between patient, admission and NACHRI children's hospital designation for children undergoing craniotomy for malignant brain tumors using a large national database. We were able to capture 9360 discharges from 2000-2009 and report novel relationships between patient, admission, and hospital factors and the clinically relevant outcomes of discharge to home and mortality. We chose routine discharge as an outcome to differentiate patients who were able to go home from patients requiring 24-hour nursing care at a skilled nursing or long-term acute care facility, inpatient rehabilitation, or further inpatient care. A routine discharge suggests an uncomplicated postoperative discharge status allowing standard care at home, an outcome important to patients, parents, and medical professionals. We report an overall routine discharge rate of 83.6%, which is lower than previously reported values.
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The in-hospital mortality rate of 1.3% was similar to mortality rates reported previously in other studies using other databases.
19,40
Patient Factors
Similar to prior studies 19, 40 we found that patients under 1 year of age were much less likely to have a routine discharge. We also report that patients under 1 year of age had a nonsignificant trend toward increased mortality, albeit with a large point estimate odds ratio of 6.9-fold increase in mortality. The power of our analysis in this subgroup is limited due to the small sample size (425 children under 1 year of age) even in this large national database.
The potential difference noted in this group may be explained by evidence that malignant brain tumors in infants are histologically and genetically different from tumors in older children. The increased mortality of children under 1 year of age undergoing brain tumor treatment has been well documented. 16, 44 Many factors contribute to this outcome, including poor tolerance of chemotherapeutic agents and radiation as well as the prevalence of posterior fossa and deep hemispheric brain tumors in young children. 15, 16, 45 In the Surveillance, Epidemiology and End Results (SEER) data reported by Hankinson et al., 19 children under 1 year of age were much more likely to have intraventricular tumors, atypical teratoid/rhabdoid tumor, choroid plexus tumors, and desmoplastic infantile astrocytoma and less likely to have cerebellar tumors and juvenile pilocytic astrocytoma. Although frequencies of medulloblastoma were similar in infants and adults in the SEER data, with the advent of medulloblastoma subtyping, it has been reported that infants with medulloblastoma are much more likely to have the Shh subtype, which entails a worse prognosis, than the most favorable Wnt subtype. 31 Another possibility is the limited access to advanced care in this group, as a recent analysis of Children's Oncology Group data showed lower-than-expected accrual of infants in clinical trials. 30 Our analysis further supports the increased focus on infantile malignant brain tumors as targets for future research into treatment. As noted, there was a significantly increased rate of routine discharge in patients 10-17 years of age compared with 18-to 20-year-old patients. This may reflect early development of adult malignancies in patients approaching the 3rd decade of life. However, further data are required to assess this phenomenon.
Intraventricular, cerebellar, brainstem, and other tumor locations were independent predictors of nonroutine discharge but were not associated with mortality. This may be secondary to the more disabling effects of these tumors and increased need for further inpatient rehabilitation and nursing care even after tumor resection, a relationship that has been shown in the current literature. 17, 23, 27, 38, 46 Our data indicate that the expected lengths of stay and postoperative regimens for patients with tumors in these locations will be prolonged compared with those for patients with hemispheric lesions.
Admission Factors
We also sought to analyze the relationship between admission factors and outcomes. Both admission source and admission type can provide an important window into utilization of a health care system. In our sample, 9.3% of children were admitted as interfacility transfers, compared with 71.4% who were admitted electively or from the emergency room of the same facility. Even after controlling for other factors, we found that those children who were transferred from another hospital and underwent a craniotomy for malignant brain tumor had a 5-fold increase in the risk of mortality and were half as likely to be routinely discharged compared with those admitted electively. The adverse effect of interfacility transfer has been noted in other conditions such as ischemic stroke in adults 43 and hemorrhagic stroke in children.
1 In our report, we are able to control for important tumor variables such as location and patient variables such as age as well as other hospital factors such as procedural volume. We believe that this finding provides further support for the importance of centralizing care and early outpatient referrals to hospitals capable of providing definitive management for malignant brain tumors, rather than attempting to provide initial management at other facilities.
Hospital Factors
Initially, we sought to investigate the relationship between outcomes and treatment at a dedicated pediatric hospital, pediatric unit in a general hospital, or nonpediatric unit in a general hospital based on NACHRI classification. The NACHRI group includes 220 self-identified pediatric hospitals and specialized pediatric units in the United States. We found that even after controlling for important patient, admission and hospital factors such as size and procedural volume, patients undergoing craniotomy for malignant brain tumors at a pediatric hospital were more likely to have a routine discharge than patients treated at adult hospitals, regardless of whether that hospital had a pediatric unit. Larger hospital size and teaching status were also independently associated with increased rate of routine discharge. The effect of treatment at a designated pediatric hospital, independent of surgeon and hospital volume, has been seen in other pediatric general surgery conditions such as appendectomy. 9, 10, 14, 17, 19, 21, 34 However, this is the first report, to our knowledge, of discharge outcome of neurosurgical patients at specialized pediatric hospitals.
Prior reports have attributed differences in outcomes after craniotomy for brain tumor 40 and ventriculoperitoneal shunt placement 8, 41 to the effects of increased surgeon and hospital volume. A recent Norwegian study, however, has suggested that relationship between surgeon volume and outcome in pediatric brain tumor cases may be absent or even paradoxically adverse.
42 Using an expanded model, we did note that procedural volume was not independently associated with discharge to home or mortality. We found that pediatric hospital designation, size, and teaching status were important explanatory factors. While increased procedural volume is ultimately associated with improved patient outcomes in univariate analysis, procedural volume drops out in our multivariate analysis as it is accounted for by the increased procedural volume inherent to treatment at children's hospitals.
Interestingly, treatment in a dedicated pediatric unit within an adult hospital was not shown to have improved outcomes compared with treatment in an adult hospital without a designated pediatric unit. This finding points to a possible fundamental difference between pediatric and nonpediatric hospitals and a pediatric hospital in terms of the tangible and intangible resources available. Accordingly, other factors beyond surgical experience and designation of a single unit for pediatric care are particularly important in the resection of pediatric malignant brain tumors. Recent advances in pediatric neurooncology care, including the availability of clinical trials and advanced medical therapy, have made specialized pediatric neurooncology increasingly important. 33 It is likely that specialists in pediatric malignant brain tumors may centralize at designated pediatric hospitals. Studies further suggest higher likelihood of treatment by fellowshiptrained surgeons and critical care staff at pediatric hospitals. 4, 6, 9, 14, 20, 26, 37, 47 It is possible that the workflow, training of personnel, and availability of amenities geared toward children provide an inherent advantage for pediatric hospitals in providing care that may manifest as improved discharge outcomes. 4, 9 These findings are consistent with a recent meta-analysis of outcomes of specialization and volume in pediatric surgery, which found that rare and complex conditions (such as pediatric malignant brain tumors) are more likely to show hospital-level effects, while common conditions were more likely to show surgeonlevel volume effects. 28 Importantly, we were not able to control for individual surgeon volume or subspecialization. The relationship between a neurosurgeon's specialization in pediatric neurosurgery and extent of resection for malignant pediatric brain tumors has previously been shown, although the effect of subspecialization could not be separated from the effect of surgeon volume. 3 It is possible that the children's hospital designation may serve, in part, as a proxy for highly subspecialized pediatric neurosurgeons rather than larger groups of lower-volume surgeons.
We did not find a difference in mortality rates based on hospital factors. Adult neurosurgery and other complex surgical oncology procedures have shown differences in mortality based on hospital factors. [5] [6] [7] [8] [9] 16 However, mortality was exquisitely rare in our series, despite the use of nationwide data from nearly a decade of discharges. Accordingly, it is uncertain whether any study could be sufficiently powered to detect differences in mortality in patients undergoing surgery for pediatric malignant brain tumors. We suggest that future research should be geared toward outcomes other than mortality.
Limitations
There are several limitations that are associated with the use of a national discharge database. Due to the nature of KID, we were unable to stratify outcomes based on surgeon volume, quality of postoperative care, and other patient-or provider-specific variables. Awareness of this additional factor may allow us to explain why institutions with a pediatric unit within a general hospital provide no additional benefit with respect to improved discharge outcomes. Addressing this issue, however, is very difficult because the KID does not include data on care after discharge or quality of postoperative care. Several other limitations also arise from using the KID itself, including difficulty in accounting for wide variations in physician practice, the 3-year nature of data collection, the lack of coding for illness severity, and the lack of patient characteristics, which have been highlighted in other studies that use the KID. 18, 24, 32, 36, 39 Lastly, the accuracy of any administrative database is depending upon accurate coding and data entry.
Conclusions
The routine analysis of nationwide discharge databases can provide hypothesis-generating results across a variety of conditions. Our analysis of administrative data for pediatric patients with a malignant brain tumor revealed novel and potentially valuable targets for future research at the patient, admission, and hospital level. We add to the body of literature that suggests that infants younger than 1 year of age have a higher risk of mortality and this subgroup of patients will benefit from further research emphasis. We also provide a series of results that may have implications for further health care system development and specialization. NACHRI-designated children's hospitals were more likely to achieve routine discharges than non-NACHRIdesignated children's hospitals. Simply creating children's units within existing adult hospitals may not be sufficient to allow the highest quality of care for pediatric patients with malignant brain tumors. However, we are not able to specifically state which elements of specialized pediatric hospitals are most important in achieving better patient outcomes.
After controlling for other patient, hospital, and admission factors, we did not find an independent effect of volume on the outcome of treatment for pediatric malignant brain tumors. The absence of this effect could be due to limitations of the KID and administrative data sets. However, in this particular subfield, hospital volume is highly associated with other hospital factors such as hospital designation, size, teaching status, and location. Since the exact mechanism of the volume-outcome effect in neurosurgery is incompletely understood, further investigation into this area is warranted.
Unfortunately, both emergent admissions and patients transferred from other hospitals were less likely to have a routine discharge and more likely to die during their hospitalization. Superspecialization of all care to a handful of very large urban centers at the cost of increased interfacility transfers may not provide increased quality of care. It would seem that earlier referral before the critical point of illness could allow patients to be referred nonemergently to specialized centers. Larger referral networks and increased use of telemedicine may allow specialty pediatric hospitals to extend their reach into the community and funnel appropriate cases to specialty centers before the patients present to an emergency department in extremis. Striking the balance of appropriate specialty care for pediatric patients with malignant brain tumors will become an important challenge as the health care landscape evolves in the years to come.
